XEELOMMIQ, created in 2013 (United States), from 496 sister brands and 17478 competing brands. XEELOMMIQ is a brand of BRISTOL-MYERS SQUIBB COMPANY, listed on the stock exchange of New York. XEELOMMIQ belongs to the Drug Manufacturers business sector.